My friend and colleague, former Congresswoman and Green Party Presidential candidate, Cynthia McKinney raised this question early on… She noted that the US had a patent on a strange, highly effective Ebola “cure”. Once the recent massive outbreak of Ebola began, she began raising a lot of important questions on this matter, which got me looking at the outbreak and how the CDC was treating it, in a more critical light…
The patented “secret serum” for Ebola was developed by a San Diego-based company, but very little is being openly discussed about the apparent cure, which ws promptly administered to and saved the lives of two Americans who contracted the disease in Liberia.
Now, some are beginning to ask the all-important question of why the drug has only been given to two white Americans, and why it was not even attempted as a treatment for anyone until two white Americans contracted the disease.
For months, Ebola has been spreading throughout West Africa. It has been diagnosed in 1,600 people and killed more than 700 in the nations of Liberia, Sierra Leone and Guinea.
But the United Nation’s World Health Organization spokesman Gregory Hartl said to CNN that health authorities “cannot start using untested drugs in the middle of an outbreak, for various reasons.”
Doctors Without Borders as well, issued a similar statement claiming the following:
“It is important to keep in mind that a large-scale provision of treatments and vaccines that are in very early stages of development has a series of scientific and ethical implications. As doctors, trying an untested drug on patients is a very difficult choice since our first priority is to do no harm, and we would not be sure that the experimental treatment would do more harm than good.”
Yes, while there is a regular, lengthy process for the Food and Drug Administration to approve new drugs, the FDA in fact has what is called a “compassionate use” regulation which exists for cases just like this, where an experimental can be given in emergency cases like this, the largest Ebola outbreak in history.
Still, neither the FDA, nor the WHO have responded to this when they were reminded of this provision, leaving many with the question of why “compassionate use” made sense for two white, American victims of the disease, but for no one else?
(Article by M.B. David)